Otonomy to Participate in SunTrust Robinson Humphrey Life Sciences Summit

Back to Jobs

SAN DIEGO , May 01, 2019 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that the company will host one-on-one meetings with investors at the 5th Annual SunTrust Robinson Humphrey

Apply Now